Pomelo Capital’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1.54M Hold
60,000
0.15% 51
2018
Q2
$1.39M Buy
+60,000
New +$1.24M 0.14% 53
2017
Q3
Sell
-25,000
Closed -$378K 138
2017
Q2
$433K Sell
25,000
-84,800
-77% -$1.02M 0.02% 111
2017
Q1
$1.21M Sell
109,800
-330,200
-75% -$4.54M 0.06% 101
2016
Q4
$6.39M Sell
440,000
-284,900
-39% -$5.23M 0.29% 81
2016
Q3
$17.8M Hold
724,900
0.82% 39
2016
Q2
$14.6M Buy
724,900
+294,900
+69% +$8.35M 0.74% 42
2016
Q1
$11.3M Buy
+430,000
New +$31.8M 0.65% 50

Other funds holding BHC

Pomelo Capital's BHC Position: Q3 2018 in Review

Pomelo Capital held its Bausch Health (BHC) position steady in Q3 2018 at 60,000 shares worth $1.54M. The position accounts for 0.15% of the portfolio, ranked #51.

Pomelo Capital first reported a position in BHC in Q1 2016 and has held it in 8 quarters since. The position peaked at $17.8M in Q3 2016. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

  • Pomelo Capital held 60,000 shares of Bausch Health worth $1.54M as of Q3 2018.
  • Pomelo Capital left its Bausch Health share count unchanged in Q3 2018.
  • Bausch Health made up 0.15% of Pomelo Capital's portfolio in Q3 2018, its #51 holding.
  • Pomelo Capital first reported a position in Bausch Health in Q1 2016 and has held it in 8 quarters since.
  • Pomelo Capital's Bausch Health position peaked at $17.8M in Q3 2016.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Pomelo Capital's 13F filing for Q3 2018, filed 14 Nov 2018.